Avantor Beats Q3, Returns to Organic Growth and Raises Full-Year Guidance
AVTR has more than doubled off its 52-week low of $7.265.
Summary
Avantor beat on Q3 revenue and adjusted EPS, returned to organic growth of 5.2%, and raised full-year organic growth, adjusted EPS and free cash flow guidance. Adjusted EBITDA margin still compressed year over year, but free cash flow of $156.2 million cut adjusted net leverage to 3.1x.
Key Events · Earnings and Guidance · AVTR
-
Q3 Sales Beat, Return to Organic Growth
Net sales of $1,698.3 million rose 4.6% reported and 5.2% organic, with VWR Distribution up 5.8% organic and Bioscience & Medtech up 3.6% organic.
-
Full-Year Guidance Raised Across Three Metrics
Organic revenue growth guidance lifted to +0.75% to +1.25% from -0.5% to +0.5%, adjusted EPS to $0.81 to $0.83 from $0.80 to $0.83, and free cash flow to $525M to $550M from $500M to $550M.
-
Margins Still Compressing
Adjusted EBITDA was $256.9 million at a 15.1% margin versus 16.5% a year ago; VWR adjusted operating margin fell to 9.7% from 11.2% on unfavorable product mix and higher SG&A.
-
Cash Flow and Leverage Improve
Q3 operating cash flow of $195.1 million produced free cash flow of $156.2 million, leaving $464.3 million of cash against $3,699.7 million gross debt and adjusted net leverage of 3.1x.
Analysis · AVTR · Industrial Applications And Services
Avantor's Q3 came in ahead of its own expectations, and more importantly, the company lifted full-year organic growth, adjusted EPS and free cash flow guidance. Organic growth of 5.2% is the first real evidence that the turnaround is working after a stretch of declining sales, and both segments contributed — VWR Distribution accelerated to 5.8% organic and Bioscience & Medtech returned to growth at 3.6%. The swing to $203.4 million of net income from a $711.8 million loss a year ago is flattered by a $105.4 million tax benefit and by last year's $785.0 million goodwill impairment, so the cleaner read is adjusted EBITDA of $256.9 million at a 15.1% margin — down from 16.5% a year ago on weaker VWR product mix and higher SG&A. Cash generation is the strongest part of the story: $156.2 million of free cash flow in the quarter and adjusted net leverage down to 3.1x. The stock is trading near its 52-week high, so the guidance raise is being delivered into an already-optimistic setup.
How filings like this one have moved
In the 30 days to Oct 28, 2026, 30.5% of the 1494 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.03%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AVTR was trading at $16.85 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $11.6B. The 52-week trading range was $7.27 to $17.45. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.